Park Nicollet Frauenshuh Cancer Center — Saint Louis Park, Minnesota

Park Nicollet Frauenshuh Cancer Center is a clinical research site located in Saint Louis Park, Minnesota, United States 55426.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Park Nicollet Frauenshuh Cancer Center has participated in 19 clinical trials with 7 currently active.

Therapeutic areas: Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue.

Sponsors: Gynecologic Oncology Group, Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Park Nicollet Frauenshuh Cancer Center?

Park Nicollet Frauenshuh Cancer Center has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Park Nicollet Frauenshuh Cancer Center conducted?

Park Nicollet Frauenshuh Cancer Center has 19 clinical trials on record, with 7 currently active. Their work covers Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue.

Is Park Nicollet Frauenshuh Cancer Center accredited by Crixeo Health?

Yes — Park Nicollet Frauenshuh Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Park Nicollet Frauenshuh Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.